论文部分内容阅读
目的分析氯吡格雷、阿司匹林联合溶栓治疗急性ST段抬高型心肌梗死的治疗效果。方法选取本院46例急性ST段抬高型心肌梗死患者的临床资料,将其按照治疗方法划分为两组,其中对照组21例患者接受阿司匹林联合溶栓治疗,治疗组25例患者接受氯吡格雷、阿司匹林联合溶栓治疗,对比两组的治疗效果。结果两组患者实施治疗后,两组患者完全性STR率对比,治疗组显著优于对照组,差异有统计学意义(P<0.05)。两组患者实施治疗前CKMB(肌酸激酶同工酶)、CK(肌酸激酶)水平比较,差异无统计学意义,实施治疗后,CKMB、CK水平比较水平明显下降,其中治疗组CKMB、CK水平显著低于同期对照组,差异有统计学意义(P<0.05)。结论采用氯吡格雷、阿司匹林联合溶栓治疗急性ST段抬高型心肌梗死,可有效提高治疗效果,有效提高患者生命质量,值得在临床医学中推广使用。
Objective To analyze the therapeutic effect of clopidogrel and aspirin combined with thrombolysis in the treatment of acute ST-segment elevation myocardial infarction. Methods The clinical data of 46 patients with acute ST-elevation myocardial infarction in our hospital were selected and divided into two groups according to the treatment method. 21 patients in the control group received aspirin combined with thrombolytic therapy, and 25 patients in the treatment group received clopidogrel Gray, aspirin thrombolytic therapy, the two groups compared the therapeutic effect. Results After the two groups of patients were treated, the complete STR rate of the two groups were compared, and the treatment group was significantly better than the control group, the difference was statistically significant (P <0.05). CKMB (creatine kinase) and CK (creatine kinase) levels before treatment were not significantly different between the two groups. After treatment, the levels of CKMB and CK were significantly decreased, and the levels of CKMB and CK The level was significantly lower than the same period control group, the difference was statistically significant (P <0.05). Conclusion Clopidogrel and aspirin combined with thrombolytic therapy for acute ST-segment elevation myocardial infarction can effectively improve the therapeutic effect and effectively improve the quality of life of patients, which is worth popularizing in clinic.